tert-Butyl 4-hydroxy-1H-pyrazole-1-carboxylate, 97%, 1g

Ethyl 3-(benzyloxy)-1-((tert-butoxycarbonyl)amino)-4-oxo-1,4-dihydropyridine-2-carboxylate, 98%, 1g

Methyl 4-((4-oxopiperidin-1-yl)methyl)benzoate, 95.0%, 5g

Boc-N-Me-D-Allo-Ile-OH, 95.0%, 1g

tert-Butyl (S)-4-amino-2-((tert-butoxycarbonyl)amino)butanoate, 97%, 25g

(2,3,6-Trimethoxyphenyl)boronic acid, 95.0%, 25g

(3R,4S,5S,7aR)-3,5,6,7a-Tetramethyl-1-oxo-N,N-diphenyl-1,3,3a,4,5,7a-hexahydroisobenzofuran-4-carboxamide, 97%, 100mg

1,10-Phenanthroline Monohydrate>99.0%(HPLC)(T)25g

(5-Chloro-2-(methylamino)phenyl)(phenyl)methanone, 98.00%, 1kg

4-Amino-2-fluorophenol>98.0%(GC)(T)1g

N-Phenylglycine ethyl ester, 95.0%, 25g

n-Alkan standard solution (C7,C8,C9,C10-C40), 19 components (each 50 mg/l) in isooctane

7-Methoxy-1-naphthaleneacetic Acid>98.0%(GC)(T)1g